By a GenomeWeb staff reporter

This article has been updated from a previous version to clarify information about Agilent's life science business and overall business in the Asia/Pacific region.

SAN FRANCISCO (GenomeWeb News) – The 30th Annual JP Morgan Healthcare Conference kicked off Monday here with several life science tools firms making presentations to some of the more than 8,000 investors and company representatives in attendance.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Chan Zuckerberg Initiative is investing in Cold Spring Harbor Laboratory's BioRxiv.

A study appearing in PLOS One finds that shortened consent forms don't affect clinical trial participants' understanding of the study.

The National Security Agency monitored signal intelligence for signs of "nefarious" genetic engineering projects, Gizmodo reports.

In Nature this week: barley genome sequenced, method for genotyping and phasing short tandem repeats, and more.